Advertisement

Topics

PerkinElmer to Hold Earnings Call on Monday, July 29, 2019

16:15 EDT 8 Jul 2019 | Businesswire

PerkinElmer, Inc.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Monday, July 29, 2019, after market close, the Company will release second quarter 2019 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert Friel, chairman and chief executive officer, Prahlad Singh, president and chief operating officer, and Jamey Mock, senior vice president and chief financial officer, will host the conference call.

To access the call, please dial (720) 405-2250 prior to the scheduled conference call time and provide the access code: 2774907. A live audio webcast of the call will also be available on the Investors section of the Company's Web site at www.perkinelmer.com.

A replay of the webcast will be available beginning at 7:00 p.m. ET, Monday, July 29, 2019 through the Investors section of the Company’s website at www.perkinelmer.com.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.8 billion in 2018, has about 12,500 employees serving customers in more than 180 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Bryan Kipp, 781-663-5583
bryan.kipp@perkinelmer.com

Media Relations:
PerkinElmer, Inc.
Brian Willinsky, 781-663-5728
brian.willinsky@perkinelmer.com

NEXT ARTICLE

More From BioPortfolio on "PerkinElmer to Hold Earnings Call on Monday, July 29, 2019"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...